Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression Post author:Sam Post published:November 8, 2017 Post category:BioPharma The positive results support the company’s planned regulatory submissions. Source: BioSpace You Might Also Like Why This SoCal Pharma Could Be Your Best Bet on Alzheimer's April 24, 2017 Bay Area Bigfoot Biomedical Bags $37M Series B Financing December 18, 2017 <b>Bluechiip Ltd</b> Half Yearly Report And Accounts February 22, 2017
